Overview
Minoxidil is tracked as a supplement in Milligram's compound library. Potassium channel opener and vasodilator.
With a half-life of ~4.2 hours, Minoxidil requires daily administration in most observed protocols. Taken orally, it has a bioavailability of approximately 95% via its primary route.
Half-life approximately 4.2 hours. Active metabolite minoxidil sulfate has a longer duration of effect. High oral bioavailability (~95%). One-compartment model.
Mechanism of Action
Minoxidil's pharmacological activity involves the following key pathways:
Primary Mechanism
Minoxidil exerts its effects through its established pharmacological pathway. Its mechanism has been characterized in published research.
Bioavailability Profile
Minoxidil has high oral bioavailability, which influences dosing strategy and administration timing.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
2.5 mg/day
Route
Oral
Frequency
2-3 times daily
Duration
Ongoing
Dose
5 mg/day
Route
Oral
Frequency
2-3 times daily
Duration
Ongoing
Frequently Asked Questions
What is oral Minoxidil and how does it work for hair loss?
Oral Minoxidil is a vasodilator originally developed as an antihypertensive drug. At low doses (0.5–5 mg/day), it promotes hair growth by opening potassium channels in vascular smooth muscle, increasing blood flow to hair follicles. It also prolongs the anagen (growth) phase of the hair cycle, increases follicular size, and stimulates vascular endothelial growth factor (VEGF) production around follicles. Its mechanism of action is independent of hormonal pathways.
How long does oral Minoxidil take to show hair growth results?
Initial shedding (a sign of follicle cycling into a new growth phase) is commonly reported in the first 2–8 weeks. New hair growth is typically observable at 3–4 months, with more significant improvements visible at 6–12 months. Despite Minoxidil's short plasma half-life of 4.2 hours, its duration of action on hair follicles extends to approximately 24 hours due to tissue-level accumulation. Hair growth results are cumulative over months.
What is the difference between oral and topical Minoxidil?
Oral Minoxidil provides systemic delivery, meaning it reaches follicles across the entire scalp uniformly rather than only where topically applied. This makes it particularly effective for diffuse thinning patterns. Studies using 5 mg oral Minoxidil once daily showed significant increases in total hair count at 12 and 24 weeks. The trade-off is increased systemic exposure, which is why low-dose protocols (1–5 mg) are used rather than the higher doses prescribed for hypertension.
What are the side effects of low-dose oral Minoxidil?
The most commonly reported side effect is hypertrichosis (increased body and facial hair growth), occurring in approximately 15% of users. Other reported effects include lightheadedness (1.7%), fluid retention (1.3%), and tachycardia (0.9%). A multicenter safety study of 1,404 patients on low-dose oral Minoxidil found the overall adverse event rate to be low at therapeutic doses of 0.5–5 mg/day. Effects are dose-dependent and generally reversible upon discontinuation.
Can oral Minoxidil be taken once daily?
Despite a plasma half-life of approximately 4.2 hours, oral Minoxidil has a duration of action of approximately 24 hours, which supports once-daily dosing for hair loss. Some protocols split the dose into twice-daily administration (e.g., 2.5 mg morning and evening) to maintain more consistent blood levels and potentially reduce cardiovascular fluctuations. Once-daily dosing at 5 mg is the most commonly studied regimen.
Is oral Minoxidil safe for long-term use?
Low-dose oral Minoxidil (0.5–5 mg/day) has been prescribed for alopecia by dermatologists with growing clinical evidence supporting its long-term safety profile. As hair loss is a chronic condition, treatment is ongoing — discontinuation typically results in gradual return to the pre-treatment hair pattern over several months. Periodic monitoring of blood pressure and heart rate is commonly observed in long-term protocols.